Nuveen Asset Management, LLC Rvl Pharmaceuticals PLC Transaction History

Nuveen Asset Management, LLC

  • $334 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$2.8 - $3.78 $244,238 - $329,721
-87,228 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$3.26 - $4.84 $62,634 - $92,990
19,213 Added 28.25%
87,228 $285,000
Q3 2020

Nov 16, 2020
BUY
$4.82 - $8.77 $217,454 - $395,658
45,115 Added 197.01%
68,015 $368,000
Q2 2020

Aug 14, 2020
BUY
$2.83 - $6.99 $64,807 - $160,071
22,900 New
22,900 $154,000

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0
View Full List

About RVL Pharmaceuticals plc

RVLP Quotes by TradingView
  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email